Clinical Trial Update: Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE) [NA]

View source ↗

Summary

Clinical trial update for Hexbio, a multi-strain probiotic, being studied in Malaysian patients with drug-resistant epilepsy; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Hexbio

Snippet

Sponsor: National University of Malaysia | Conditions: Epilepsies Refractory | NA | Status: ACTIVE_NOT_RECRUITING